iSpecimen Inc
NASDAQ:ISPC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Alignment Healthcare LLC
NASDAQ:ALHC
|
US |
|
Cosmo First Ltd
NSE:COSMOFIRST
|
IN |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (8.9), the stock would be worth $2.81 (2 055% upside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.4 | $0.13 |
0%
|
| 3-Year Average | 8.9 | $2.81 |
+2 055%
|
| 5-Year Average | 11.2 | $3.53 |
+2 608%
|
| Industry Average | 3.1 | $0.99 |
+657%
|
| Country Average | 2.5 | $0.79 |
+509%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
iSpecimen Inc
NASDAQ:ISPC
|
3.9m USD | 0.4 | -0.1 | |
| JP |
|
Medical Data Vision Co Ltd
TSE:3902
|
37.9T JPY | 20.7 | 227.5 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 8 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
26.4B USD | 3.7 | 29 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.8B AUD | 37.2 | 61.7 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 2.6 | 20.5 | |
| SE |
|
Sectra AB
STO:SECT B
|
51.8B SEK | 26.8 | 96.4 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.9B USD | 1.2 | 42.4 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.4B USD | 4.5 | 18.6 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
19.3B CNY | 3.4 | -62.7 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 17.2 | -328 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.5 |
| Median | 2.5 |
| 70th Percentile | 4.8 |
| Max | 147 580.5 |
Other Multiples
iSpecimen Inc
Glance View
iSpecimen, Inc. operates as healthcare organization that engages in procurement of human biospecimens. The company is headquartered in Lexington, Massachusetts and currently employs 59 full-time employees. The company went IPO on 2021-06-17. The firm designed iSpecimen Marketplace platform to transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. The Company’s marketplace platform ingests de-identified healthcare data provided by healthcare supply partners. The iSpecimen Marketplace supports the supply chain management and bioprocurement process for specimens and associated data. The Company’s platform helps with administrating and reporting function for researchers, suppliers, and internal personnel, including user and compliance management. The firm serves to biopharmaceutical companies, in vitro diagnostic (IVD) companies, and government/academic institutions.
